The document discusses various potential roles that states or state-designated entities (SDEs) can play in supporting electronic prescribing (ePrescribing) to help meet meaningful use requirements. It outlines conducting a gap analysis of ePrescribing capabilities; tracking adoption; developing education campaigns; examining regulations; coordinating stakeholder strategies; engaging pharmacies; updating Medicaid; increasing provider awareness; facilitating electronic prescribing of controlled substances; and monitoring emerging issues. Examples from Minnesota, Rhode Island, Florida and Tennessee are provided.